256 related articles for article (PubMed ID: 34692476)
21. Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study.
Zhou S; Liu Y; Liu K; Zhang J; Liang H; Wu Y; Ye H; Liang Y; Zhang J; Huang W
Front Immunol; 2023; 14():1343504. PubMed ID: 38187385
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma.
Shen D; Wang J; Wu J; Chen S; Li J; Liu J; Chen Q; Jiang Y
J Thorac Dis; 2021 Mar; 13(3):1760-1768. PubMed ID: 33841966
[TBL] [Abstract][Full Text] [Related]
23. Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer.
Shen J; Gu L; Qi Y; Yao Y; Lu S; Chen Z
Front Immunol; 2023; 14():1268251. PubMed ID: 37818382
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Shu CA; Gainor JF; Awad MM; Chiuzan C; Grigg CM; Pabani A; Garofano RF; Stoopler MB; Cheng SK; White A; Lanuti M; D'Ovidio F; Bacchetta M; Sonett JR; Saqi A; Rizvi NA
Lancet Oncol; 2020 Jun; 21(6):786-795. PubMed ID: 32386568
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer.
Chen Y; Yan B; Xu F; Hui Z; Zhao G; Liu J; Zhang H; Zeng Z; Zhang R; Provencio M; Ren X; You J
Transl Lung Cancer Res; 2021 May; 10(5):2193-2204. PubMed ID: 34164269
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?
Yao Y; Tang D; Gao W; Zhang H
Front Surg; 2022; 9():843987. PubMed ID: 35449550
[TBL] [Abstract][Full Text] [Related]
27. An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer.
Qi Y; Gu L; Shen J; Yao Y; Zhao Y; Lu S; Chen Z
Front Oncol; 2023; 13():1194100. PubMed ID: 37655106
[TBL] [Abstract][Full Text] [Related]
28. Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer.
Wu J; Hou L; E H; Zhao Y; Yu X; Xu L; Ning Y; Deng J; Sun K; Zhang J; Wu C; Zhu Y; Zhao D; She Y; Su C; Chen C
Lung Cancer; 2022 Mar; 165():115-123. PubMed ID: 35123154
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Schilder RJ; Goldberg M; Millenson MM; Movsas B; Rogatko A; Rogers B; Langer CJ
Lung Cancer; 2000 Jan; 27(1):37-45. PubMed ID: 10672782
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer.
Reuss JE; Anagnostou V; Cottrell TR; Smith KN; Verde F; Zahurak M; Lanis M; Murray JC; Chan HY; McCarthy C; Wang D; White JR; Yang S; Battafarano R; Broderick S; Bush E; Brock M; Ha J; Jones D; Merghoub T; Taube J; Velculescu VE; Rosner G; Illei P; Pardoll DM; Topalian S; Naidoo J; Levy B; Hellmann M; Brahmer JR; Chaft JE; Forde PM
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32929052
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience.
Eichhorn F; Klotz LV; Kriegsmann M; Bischoff H; Schneider MA; Muley T; Kriegsmann K; Haberkorn U; Heussel CP; Savai R; Zoernig I; Jaeger D; Thomas M; Hoffmann H; Winter H; Eichhorn ME
Lung Cancer; 2021 Mar; 153():150-157. PubMed ID: 33529989
[TBL] [Abstract][Full Text] [Related]
32. Systematic Review of Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer.
Cao C; Guo A; Chen C; Chakos A; Bott M; Yang CJ; Zielinski R; Melfi F
Semin Thorac Cardiovasc Surg; 2021; 33(3):850-857. PubMed ID: 33444765
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant vs Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer.
Martins RS; Razi SS; Alnajar A; Poulikidis K; Latif MJ; Luo J; Bhora FY
Ann Thorac Surg; 2024 Jan; ():. PubMed ID: 38290596
[TBL] [Abstract][Full Text] [Related]
34. Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study.
Hui B; Wang X; Wang X; Qiao B; Duan J; Shang R; Yang W; Wang J; Chen K; Yang F; Jiang T; Lei J
Int J Surg; 2023 Aug; 109(8):2286-2292. PubMed ID: 37161431
[TBL] [Abstract][Full Text] [Related]
35. Analysis of treatment-related adverse events and wound complications of surgical resection after neoadjuvant chemoimmunotherapy for non-small cell lung cancer.
Li Y; Hu X; Zhang R; Wu N; Xia Q; Gu P
Int Wound J; 2024 Mar; 21(3):e14831. PubMed ID: 38484730
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC).
Wang Q; Qi C; Luo J; Xu N; Xu MT; Qiang Y; Zhang C; Shen Y
Front Oncol; 2023; 13():1239451. PubMed ID: 38205138
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.
Duan H; Wang T; Luo Z; Tong L; Dong X; Zhang Y; Afzal MZ; Correale P; Liu H; Jiang T; Yan X
Transl Lung Cancer Res; 2021 Feb; 10(2):1020-1028. PubMed ID: 33718040
[TBL] [Abstract][Full Text] [Related]
38. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
39. Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
Tong BC; Gu L; Wang X; Wigle DA; Phillips JD; Harpole DH; Klapper JA; Sporn T; Ready NE; D'Amico TA
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):427-436. PubMed ID: 33985811
[TBL] [Abstract][Full Text] [Related]
40. The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.
Jiang L; Huang J; Jiang S; Rong W; Shen Y; Li C; Tian Y; Ning J; Chen X; Yang Y; Ding Z; Li Z; Luo Q
Cancer Immunol Immunother; 2021 Aug; 70(8):2313-2321. PubMed ID: 33512555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
